Matches in SemOpenAlex for { <https://semopenalex.org/work/W2941288979> ?p ?o ?g. }
- W2941288979 endingPage "10" @default.
- W2941288979 startingPage "1" @default.
- W2941288979 abstract "Pharmaceuticals in surface waters have raised significant concern in recent years for their potential environmental effects. This study identified that at present a total of 477 substances (including 66 metabolites and transformation products) have been analyzed in European surface waters. Around 60% (284) of these compounds belonging to 16 different therapeutic groups were positively detected in one or more of 33 European countries. To conveniently and effectively prioritize potential high-risk compounds, an optimized method that considers the frequency of concentrations above predicted no effects levels was developed on the basis of the traditional method, and it was then used to identify and screen candidate priority pollutants in European surface waters. The results proved the feasibility and advantages of the optimized method. Pharmaceuticals detected in European surface waters were classified into 5 categories (high, moderate, endurable, negligible and safe) depending on their potential environmental effects and the distribution of pharmaceuticals. Circa 9% (45 out of 477) analyzed compounds showed a potential environmental risk to aquatic ecosystems. Among these 45 compounds, 12 compounds were indicated to have high environmental risk in aquatic environments, while 17 and 7 compounds showed moderate and small-scale environmental risks, respectively." @default.
- W2941288979 created "2019-05-03" @default.
- W2941288979 creator A5032894156 @default.
- W2941288979 creator A5036050915 @default.
- W2941288979 creator A5038232471 @default.
- W2941288979 creator A5045077051 @default.
- W2941288979 creator A5075086719 @default.
- W2941288979 creator A5089154321 @default.
- W2941288979 date "2019-07-01" @default.
- W2941288979 modified "2023-10-10" @default.
- W2941288979 title "Optimization of screening-level risk assessment and priority selection of emerging pollutants – The case of pharmaceuticals in European surface waters" @default.
- W2941288979 cites W1964190160 @default.
- W2941288979 cites W1964542933 @default.
- W2941288979 cites W1966206163 @default.
- W2941288979 cites W1966759773 @default.
- W2941288979 cites W1969218162 @default.
- W2941288979 cites W1984298514 @default.
- W2941288979 cites W2000863285 @default.
- W2941288979 cites W2011398241 @default.
- W2941288979 cites W2014226326 @default.
- W2941288979 cites W2021096668 @default.
- W2941288979 cites W2022759827 @default.
- W2941288979 cites W2024697402 @default.
- W2941288979 cites W2027200390 @default.
- W2941288979 cites W2027454891 @default.
- W2941288979 cites W2032789346 @default.
- W2941288979 cites W2037213155 @default.
- W2941288979 cites W2037766564 @default.
- W2941288979 cites W2041683734 @default.
- W2941288979 cites W2052359006 @default.
- W2941288979 cites W2063244562 @default.
- W2941288979 cites W2067326057 @default.
- W2941288979 cites W2071430420 @default.
- W2941288979 cites W2072858339 @default.
- W2941288979 cites W2078413678 @default.
- W2941288979 cites W2085215470 @default.
- W2941288979 cites W2092894272 @default.
- W2941288979 cites W2092993529 @default.
- W2941288979 cites W2100014672 @default.
- W2941288979 cites W2126277206 @default.
- W2941288979 cites W2127041358 @default.
- W2941288979 cites W2128153965 @default.
- W2941288979 cites W2151745588 @default.
- W2941288979 cites W2159477133 @default.
- W2941288979 cites W2168156515 @default.
- W2941288979 cites W2169412126 @default.
- W2941288979 cites W2177317049 @default.
- W2941288979 cites W2297938101 @default.
- W2941288979 cites W2332096337 @default.
- W2941288979 cites W2344578960 @default.
- W2941288979 cites W2406870242 @default.
- W2941288979 cites W2440430819 @default.
- W2941288979 cites W2517197954 @default.
- W2941288979 cites W2544886233 @default.
- W2941288979 cites W2592813904 @default.
- W2941288979 cites W2624992950 @default.
- W2941288979 cites W2675089821 @default.
- W2941288979 cites W2730566061 @default.
- W2941288979 cites W2779446954 @default.
- W2941288979 cites W2789444400 @default.
- W2941288979 cites W2789698926 @default.
- W2941288979 cites W2791991839 @default.
- W2941288979 cites W2793387757 @default.
- W2941288979 cites W2801411913 @default.
- W2941288979 cites W2804151466 @default.
- W2941288979 cites W2890219520 @default.
- W2941288979 doi "https://doi.org/10.1016/j.envint.2019.04.034" @default.
- W2941288979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31029973" @default.
- W2941288979 hasPublicationYear "2019" @default.
- W2941288979 type Work @default.
- W2941288979 sameAs 2941288979 @default.
- W2941288979 citedByCount "187" @default.
- W2941288979 countsByYear W29412889792019 @default.
- W2941288979 countsByYear W29412889792020 @default.
- W2941288979 countsByYear W29412889792021 @default.
- W2941288979 countsByYear W29412889792022 @default.
- W2941288979 countsByYear W29412889792023 @default.
- W2941288979 crossrefType "journal-article" @default.
- W2941288979 hasAuthorship W2941288979A5032894156 @default.
- W2941288979 hasAuthorship W2941288979A5036050915 @default.
- W2941288979 hasAuthorship W2941288979A5038232471 @default.
- W2941288979 hasAuthorship W2941288979A5045077051 @default.
- W2941288979 hasAuthorship W2941288979A5075086719 @default.
- W2941288979 hasAuthorship W2941288979A5089154321 @default.
- W2941288979 hasBestOaLocation W29412889791 @default.
- W2941288979 hasConcept C105639569 @default.
- W2941288979 hasConcept C107872376 @default.
- W2941288979 hasConcept C12174686 @default.
- W2941288979 hasConcept C144133560 @default.
- W2941288979 hasConcept C175327387 @default.
- W2941288979 hasConcept C185592680 @default.
- W2941288979 hasConcept C18903297 @default.
- W2941288979 hasConcept C2910001868 @default.
- W2941288979 hasConcept C2984109670 @default.
- W2941288979 hasConcept C2991714712 @default.
- W2941288979 hasConcept C38652104 @default.
- W2941288979 hasConcept C39432304 @default.
- W2941288979 hasConcept C41008148 @default.